← Pharmacy curriculum
Module 8010 lessonsNaS reconciliation of RxPrep 2023, the 2025 SCCM PADIS focused update, the SCCM ICU Liberation framework, and current FDA and DailyMed labeling

ICU Analgesia, Sedation, and Delirium

Measure pain, choose the lightest effective sedation, detect acute brain dysfunction, and organize recovery as one connected critical-care system.

01

Use self report, CPOT, and BPS appropriately while recognizing the limits of vital signs and paralysis.

02

Select and monitor fentanyl, morphine, and hydromorphone through organ function, hemodynamics, duration, and metabolite exposure.

03

Apply analgesia-first and multimodal strategies without stacking sedating medicines without a mechanism or stop rule.

04

Set and reassess patient-specific RASS targets and coordinate awakening with breathing assessment when safe.

05

Choose dexmedetomidine, propofol, or a benzodiazepine from the sedation goal and clinical phenotype.

06

Prevent, recognize, and respond to propofol infusion syndrome, cardiorespiratory depression, and aseptic-delivery failures.

07

Use dexmedetomidine safely around bradycardia, hypotension, loading effects, arousability, and extubation.

08

Detect hypoactive and hyperactive delirium through repeated validated assessment and a structured differential.

09

Treat delirium by correcting causes and restoring the brain environment while respecting current antipsychotic evidence limits.

10

Use the ABCDEF bundle, enhanced mobility, sleep protection, and transition planning to reduce preventable post-ICU disability.

80.01

Measure Pain Before Treating Agitation

Pain is common, frequently procedural, and often hidden by intubation or neurologic illness. The assessment method must match the patient's ability to communicate and must be repeated after intervention.

What to learn
  • Self report
  • CPOT
  • BPS
  • Procedure pain
  • Reassessment
Pain signalMeasure pain before treating agitation
01AskSelf report

Use the patient's report whenever communication is reliable.

02ObserveCPOT or BPS

Use a validated behavioral tool when self report is not possible.

03RecheckResponse

Trend comfort, function, ventilation, and toxicity after treatment.

Use self report whenever it is reliable

An alert patient remains the best source of pain information. Intubation does not remove the ability to report through pointing, writing, or communication aids. Treat the report as primary evidence and place behavior and physiology around it.

Use validated behavior when communication fails

CPOT and BPS structure facial expression, movement, muscle tension, and ventilator interaction. They are not interchangeable with pulse or blood pressure, and paralysis, deep sedation, neuropathy, or brain injury can suppress observable behavior.

Anticipate procedural pain

Turning, wound care, drains, suctioning, and line procedures can cause severe episodic pain despite an acceptable resting score. Plan analgesia before the event, use nonpharmacologic support, and reassess soon afterward.

0 of 1 answered
01A communicative intubated patient reports severe pain while heart rate is normal. Which finding should guide treatment most directly?
Answer every question to submit.
80.02

Choose the Opioid Through the Patient

Correctly dosed intravenous opioids can all provide analgesia, but metabolites, histamine release, organ failure, prior exposure, interaction, and infusion duration create different bedside consequences.

What to learn
  • Fentanyl
  • Morphine
  • Hydromorphone
  • Kidney function
  • Accumulation
Opioid mapThe patient chooses the opioid more than the pain score does
01KidneyMetabolites

Renal dysfunction increases risk from active or neurotoxic metabolites.

02PressureHistamine and tone

Hemodynamic reserve changes the cost of each option.

03TimeContext sensitive

Long infusions can extend recovery even after a short initial half life.

Use fentanyl for rapid titration with caveats

Fentanyl has rapid onset, little histamine release, and no active renally eliminated analgesic metabolite. It remains highly potent, interacts through CYP3A4, and can have prolonged offset after high-dose or long infusions because context-sensitive recovery changes with exposure.

Respect morphine metabolites and hemodynamics

Morphine can release histamine and forms metabolites that accumulate as kidney function declines. Prolonged respiratory depression, sedation, myoclonus, and neurotoxicity should trigger an exposure and organ-function review rather than automatic sedative escalation.

Do not call hydromorphone renal neutral

Hydromorphone is potent and can be useful when morphine is undesirable, but hydromorphone-3-glucuronide can accumulate and contribute to agitation or myoclonus. Dose, interval, kidney trajectory, and concurrent depressants still require review.

0 of 1 answered
01Which change most strongly explains new myoclonus during repeated opioid dosing?
Answer every question to submit.
80.03

Treat Pain Before Adding Hypnosis

Analgesia-first sedation asks whether pain is the driver before adding a hypnotic. Multimodal care uses distinct mechanisms to improve comfort and function while limiting avoidable opioid exposure.

What to learn
  • Analgosedation
  • Acetaminophen
  • Ketamine
  • Regional care
  • Opioid sparing
Analgesia firstReduce pain, then decide what sedation remains necessary
01TreatPrimary driver

Address pain before escalating a hypnotic for apparent agitation.

02CombineDifferent mechanisms

Use selected nonopioid and regional strategies to reduce opioid burden.

03ProtectFunction

Preserve breathing, wakefulness, mobility, and communication when possible.

Start with the driver

Pain can appear as agitation, tachypnea, ventilator dyssynchrony, hypertension, or withdrawal from care. Assess and treat pain first unless a separate emergency requires immediate deeper sedation.

Build a mechanism-based combination

Selected acetaminophen, regional or local techniques, neuropathic agents, and low-dose ketamine can reduce opioid requirements. Kidney, liver, bleeding, hemodynamic, cognitive, and interaction risk determine whether each option belongs.

Use ketamine as an adjunct, not a mythology

NMDA antagonism can support opioid-tolerant or selected severe pain, but emergence phenomena, sympathetic effects, dose, monitoring, and the patient's neurologic and cardiovascular context matter. Ketamine does not make airway or cognition surveillance optional.

0 of 1 answered
01A postoperative patient is agitated only during wound care and has a high CPOT score. What is the best first strategy?
Answer every question to submit.
80.04

Make Sedation a Measured Intervention

Sedation depth is a clinical exposure. A written target, repeated RASS assessment, and a reason for any deep target allow the team to distinguish necessary unconsciousness from accumulation and inertia.

What to learn
  • RASS
  • Light sedation
  • Deep sedation
  • Awakening trial
  • Breathing trial
Targeted sedationA written depth target turns an infusion into a controlled intervention
01SetRASS goal

Choose the lightest depth that safely meets the clinical need.

02TitrateOne trajectory

Match dose changes to pain, synchrony, procedures, and neurologic goals.

03WakeDaily readiness

Use protocolized awakening and breathing assessment when safe.

Use RASS as a shared language

RASS spans positive agitation through zero alertness to negative sedation. Establish a target before titration and investigate a mismatch rather than merely accepting the pump rate that produced it.

Prefer light sedation when safe

Light sedation supports communication, mobility, neurologic assessment, delirium detection, and ventilator liberation. Deeper targets can be appropriate for selected paralysis, severe hypoxemia, status epilepticus, intracranial pressure, procedures, or dangerous dyssynchrony, but the reason and duration must remain visible.

Coordinate awakening and breathing

Protocolized spontaneous awakening and breathing assessments should be paired when safety criteria are met. This is not an order to abruptly stop every infusion despite seizures, paralysis, severe hypoxemia, or another active contraindication.

0 of 1 answered
01A stable patient has a RASS of minus 4 despite a target of minus 1 to 0. What should happen next?
Answer every question to submit.
80.05

Choose the Sedative by the Recovery Goal

Dexmedetomidine, propofol, and benzodiazepines are not interchangeable. Desired depth, arousability, hemodynamics, ventilation, neurologic examination, withdrawal, seizure, organ function, and liberation timing define the tradeoff.

What to learn
  • Dexmedetomidine
  • Propofol
  • Benzodiazepines
  • Arousability
  • Withdrawal
Sedative choiceSelect by goal, physiology, and recovery plan
01DexmedetomidineArousable

Supports light sedation with little respiratory depression but can slow rate and pressure.

02PropofolRapid control

Provides fast titration but can depress circulation and carries metabolic toxicity.

03BenzodiazepineSpecific indication

Retain for seizure or alcohol and benzodiazepine withdrawal rather than routine default use.

Use the current PADIS distinction

The 2025 PADIS focused update conditionally suggests dexmedetomidine over propofol for mechanically ventilated adults when light sedation or reducing delirium is a leading priority. This is not a claim that one drug is universally superior.

Choose propofol for rapid titration when physiology allows

Propofol supports fast changes in depth and neurologic reassessment but can cause hypotension, apnea, cardiac depression, hypertriglyceridemia, and propofol infusion syndrome. It is labeled for ICU sedation in intubated mechanically ventilated adults.

Keep benzodiazepines for indications they treat

Benzodiazepines remain central for seizures and alcohol or benzodiazepine withdrawal. Routine default infusion can prolong awakening through parent drug or active metabolite accumulation and is associated with delirium risk.

0 of 1 answered
01Which patient most closely fits the 2025 conditional preference for dexmedetomidine over propofol?
Answer every question to submit.
80.06

Run Propofol as a High-Reliability System

Propofol's rapid kinetics can be valuable only when titration, cardiorespiratory monitoring, metabolic surveillance, lipid exposure, aseptic handling, and product-specific delivery requirements remain tightly controlled.

What to learn
  • Hypotension
  • Apnea
  • PRIS
  • Triglycerides
  • Asepsis
Propofol surveillanceRapid recovery requires disciplined metabolic and delivery safety
01CirculationDose response

Titrate slowly and monitor hypotension, apnea, and cardiac depression.

02MetabolismPRIS

Watch acid base state, lactate, rhythm, muscle injury, kidney, and lipids.

03DeliveryAsepsis

Use dedicated handling, tubing, and discard intervals from current labeling.

Titrate slowly to effect

Current labeling directs continuous infusion with slow adjustments and time between changes to reduce hypotension and acute overdose. Rapid bolus or stacked escalation is especially hazardous in older, debilitated, unstable, or heavily premedicated patients.

Recognize propofol infusion syndrome early

Unexplained metabolic acidosis, rising lactate, rhabdomyolysis, hyperkalemia, kidney injury, lipemia, hepatomegaly, ECG change, bradyarrhythmia, or cardiac failure during substantial exposure should trigger urgent evaluation and discontinuation rather than waiting for a complete textbook cluster.

Treat asepsis as pharmacology

The lipid emulsion can support microbial growth. Prepare and access with strict aseptic technique, use label-directed containers and dedicated administration systems, mark times, and replace or discard the product and tubing within current label and institutional intervals.

0 of 1 answered
01A patient on high-dose propofol develops lactic acidosis, hyperkalemia, rising CK, kidney injury, and bradyarrhythmia. What is the priority?
Answer every question to submit.
80.07

Use Arousable Sedation Without Ignoring Hemodynamics

Dexmedetomidine provides alpha-2-mediated sympatholysis and cooperative sedation with limited respiratory depression. Bradycardia, hypotension, loading-related hypertension, withdrawal after prolonged exposure, and hepatic handling remain important.

What to learn
  • Alpha-2
  • Bradycardia
  • Hypotension
  • Extubation
  • Withdrawal
Alpha-2 sedationWakeful sedation trades respiratory stability for hemodynamic risk
01StateArousable

Patients can remain interactive and may continue through extubation.

02RateBradycardia

Loading and high exposure can produce clinically important slowing.

03PressureBiphasic

Transient hypertension or later hypotension requires context and titration.

Match arousability to the goal

Patients can often awaken and interact with stimulation, which supports neurologic assessment and ventilator liberation. Current labeling permits continuation before, during, and after extubation without a mandatory stop before the tube is removed.

Anticipate rate and pressure effects

Central sympatholysis can cause bradycardia and hypotension, especially with hypovolemia, conduction disease, older age, or concurrent negative chronotropes. Loading can create transient hypertension through peripheral vascular alpha-2 effects.

Separate labeling from broader practice

Current ICU labeling describes continuous infusion not exceeding 24 hours, although longer use occurs in practice. Teach the labeled boundary explicitly, then require local protocol, evidence review, withdrawal surveillance, and careful taper planning for any extended exposure.

0 of 1 answered
01A stable patient is ready for extubation on low-dose dexmedetomidine. What does current labeling permit?
Answer every question to submit.
80.08

Detect Acute Brain Dysfunction

Delirium is acute and fluctuating dysfunction of attention and cognition. It may be hyperactive, hypoactive, or mixed, and the quiet form is easily missed unless the team screens systematically.

What to learn
  • CAM-ICU
  • ICDSC
  • Inattention
  • Fluctuation
  • Differential
Acute brain failureDetect delirium through attention and fluctuation, not appearance alone
01ArousalRASS first

Establish whether the patient can participate in delirium assessment.

02AttentionCAM-ICU or ICDSC

Use a validated tool repeatedly across the changing day.

03CauseReconstruct exposure

Search infection, drugs, withdrawal, hypoxia, metabolic injury, pain, and environment.

Establish arousal before the delirium tool

Use RASS first to determine whether the patient can engage. Then apply CAM-ICU or ICDSC repeatedly rather than using words such as confused or appropriate without a validated assessment.

Search for causes in parallel

Review oxygenation, ventilation, infection, perfusion, glucose, electrolytes, kidney and liver function, neurologic events, pain, retention, constipation, sleep, sensory loss, withdrawal, and every psychoactive or anticholinergic exposure.

Do not miss hypoactive delirium

A quiet patient can have severe inattention, disorganized thinking, and fluctuating arousal. Calm appearance does not equal an intact brain, and new dysfunction should not be assigned automatically to age or personality.

0 of 1 answered
01A calm patient is newly inattentive with fluctuating awareness. What is the best next step?
Answer every question to submit.
80.09

Correct Drivers and Restore the Brain Environment

Delirium management begins with cause correction and an environment that supports wakefulness, orientation, sleep, mobility, hearing, vision, and family connection. Routine antipsychotic use does not have established outcome benefit.

What to learn
  • Cause correction
  • Orientation
  • Sleep
  • Antipsychotics
  • Melatonin
Delirium responseRemove drivers and restore orientation before reaching for suppression
01CorrectReversible causes

Treat pain, hypoxia, infection, withdrawal, retention, and medication toxicity.

02RestoreBrain environment

Use daylight, sleep protection, hearing, vision, family, and mobility.

03ReserveSymptom control

Antipsychotics do not have proven routine outcome benefit and require a defined target.

Remove the drivers

Treat hypoxia, hypercapnia, infection, shock, metabolic disturbance, withdrawal, pain, retention, constipation, and medication toxicity. Reduce deliriogenic exposure while avoiding abrupt withdrawal from drugs that require taper or substitution.

Rebuild circadian and sensory context

Provide daylight, quiet nights, clustered care, hearing and vision aids, clocks, orientation, family presence, mobility, hydration, and restraint review. The 2025 update conditionally suggests melatonin for sleep, not as a proven delirium cure.

Use antipsychotics with evidence humility

The 2025 focused update could not recommend for or against antipsychotics over usual care for ICU delirium treatment. If short-term use is chosen for dangerous distress or interference with essential care, name the target, screen QT and movement risk, use the minimum exposure, and stop when the target resolves.

0 of 1 answered
01A delirious patient is calm and medically stable after reversible causes are being addressed. Which strategy best matches current evidence?
Answer every question to submit.
80.10

Build Recovery Into Every ICU Day

The ABCDEF bundle connects symptom control, awakening, breathing, sedative choice, delirium, mobility, and family. Recovery begins before extubation and continues through transition because cognitive, physical, sleep, and psychiatric injury can persist.

What to learn
  • ABCDEF
  • Mobility
  • Family
  • Sleep
  • PICS
ICU liberationRecovery begins while organ support is still running
01CoordinateABCDEF

Link pain, awakening, breathing, sedative choice, delirium, mobility, and family.

02MobilizeFunction

Use enhanced rehabilitation when stable enough rather than waiting for discharge.

03TransitionPICS prevention

Reconcile exposure, cognition, sleep, weakness, and follow-up at every handoff.

Coordinate the ABCDEF bundle

Assess and manage pain, conduct awakening and breathing trials, choose analgesia and sedation deliberately, assess and manage delirium, mobilize early, and engage family. Each element changes the safety and success of the others.

Mobilize with a safety system

The 2025 PADIS update conditionally suggests enhanced mobilization or rehabilitation over usual care. Screen cardiovascular, respiratory, neurologic, line, and staffing safety, then progress from positioning and sitting to standing and ambulation as tolerated.

Plan for post-intensive care syndrome

Survivors and families can experience weakness, cognitive impairment, anxiety, depression, traumatic stress, sleep disruption, and medication-related problems. Handoffs should reconcile exposures, function, new deficits, education, equipment, and follow-up responsibility.

0 of 1 answered
01Which plan best represents ICU liberation?
Answer every question to submit.

Check the connections.

Each attempt draws 10 questions from the complete 112 question bank.

112 questions in this module bank10 questions per attempt

Each attempt draws a fresh set and rearranges the answer choices.

Current clinical foundation.

Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.

  1. SCCM: 2025 Focused Update to the Adult PADIS Guidelines
  2. SCCM: 2018 Adult PADIS Guidelines
  3. SCCM: ICU Liberation ABCDEF Bundle
  4. DailyMed: Propofol Injectable Emulsion
  5. DailyMed: Dexmedetomidine Hydrochloride Injection
PharmacyOpen tools